Article 23 Jan 2024 USPTO Issues "Reasonable" Guidance On Enablement Under Amgen V. Sanofi United States IP
Article 29 Dec 2023 USPTO Says Prior Art Date Of AIA Patents Is Not Limited By Dynamic Drinkware United States IP
Article 16 Nov 2023 A Look At FDA's Proposed Changes To Labeling For Biosimilars And Interchangeable Biosimilars United States Healthcare